Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.
The UK drugs regulator has removed postoperative pain from prolonged-release opioid licences due to increased risks of ...
Catarina Craveiro, a biomedical research technician from Lisbon, had been hobbled by lower back pain from scoliosis since ...
The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests ...
Study uncovers new insights into pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ ...
Fresh research reveals how specific foods can reduce chronic pain intensity regardless of weight, potentially transforming ...
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...